A phase 3 study of BB2603
Latest Information Update: 16 Nov 2023
At a glance
- Drugs Terbinafine (Primary)
- Indications Onychomycosis
- Focus Registrational; Therapeutic Use
- Sponsors Blueberry Therapeutics
Most Recent Events
- 16 Nov 2023 New trial record